The COVID-19 pandemic has highlighted common areas of uncertainty associated with evaluating the clinical and economic value of novel interventions. It has forced us to reconsider how evidence is ...

Notwithstanding general recognition of the criteria for decision-making capacity, there is a divergence of opinion about which criteria should be included and how they should be applied. 48–50 ...